Date Received: 02-07-2025
Date Published: 02-07-2025
##submissions.doi##: https://doi.org/10.31817/tckhnnvn.2016.14.10.
Views
Downloads
How to Cite:
CHARACTERIZATION OF KTY-06 FIELD PRRS STRAIN ISOLATED IN VIETNAM AND EVALUATION OF ANTIBODY PRODUCING OF THE INACTIVATED VIRUS IN PIG
,
Trinh Dinh Thau
,
Yamaguchi Ryoji
,
Nguyen Van Giap
,
Luong Quoc Hung
,
Nguyen Thi Yen
,
Nguyen Huu Nam
,
Nguyen Thi Hoa
Keywords
Biology, antigenicity, PRRSV, KTY-06, Vietnam
Abstract
KTY-06 virus strain was isolated from 2-week-old piglet in a PRRS outbreak in Northern Vietnam in 2015 that had clinical signs, gross findings, and microsopic lesions specific with HP-PRRS. Results of a phylogenetic analysis of the open reading frame 5 region of the KTY-06 strain showed it to be a North American genotype and classified into sublineage 8.7, in which highly pathogenic Chinese PRRSV strains are also clustered. Passaging in Marc-145 cells, KTY-06 gradually induced 35% up to 100% CPE between 36 to 60 hours post inoculation. The titer of KTY-06 was 1.74 x 105 TCID50/25µl. Of which, titer of the free viruses in the supernatant was higher than the titer of the cell associated virusese. Formalin-inactivated KTY-06 was able to stimulate pigs to produce specific antibodies against PRRSV. The immune response was detectable 14 day post immunization (dpi) (S/P ratio was 0.697 ± 0.271), peaked at 42 dpi (S/P ratio was 1.197 ± 0.256), and then declined at 49 dpi. The results suggest that KTY-06 was a candidate for strain selection for producing PRRS vaccine.
References
Baron, T., et al., Report on the first outbreaks of the porcine reproductive and respiratory syndrome (PRRS) in France (1992). Diagnosis and viral isolation. Ann Rech Vet,. 23(2): 161-166.
Goldberg, T.L., et al., (2000). Genetic, geographical and temporal variation of porcine reproductive and respiratory syndrome virus in Illinois. Journal of General Virology, 81(1): 171-179.
Habib, M., et al. (2006). Inactivation of infectious bursal disease virus by binary ethylenimine and formalin. Journal of Zhejiang University Science, 7(4): 320-323.
Keffaber, K.K. (1989). Reproductive failure of unknown etiology. American Association of Swine Practitioners Newsletter, 1: 1-9.
Kim, H., et al. (1993). Enhanced replication of porcine reproductive and respiratory syndrome (PRRS) virus in a homogeneous subpopulation of MA-104 cell line. Archives of virology, 133(3-4): 477-483.
LAN, N.T., et al. (2005). The growth profiles of three types of canine distemper virus on Vero cells expressing canine signaling lymphocyte activation molecule. Journal of veterinary medical science, 67(5): 491-495.
Mengeling, W., K. Lager, and A. Vorwald (1996). Alveolar macrophages as a diagnostic sample for detecting natural infection of pigs with porcine reproductive and respiratory syndrome virus. Journal of Veterinary Diagnostic Investigation, 8(2): 238-240.
Meulenberg, J.J. (2000). PRRSV, the virus. Veterinary research, 31(1): 11-21.
Neumann, E.J., et al. (2005). Assessment of the economic impact of porcine reproductive and respiratory syndrome on swine production in the United States. Journal of the American Veterinary Medical Association, 227(3): 385-392.
Nodelijk, G., et al. (2001). A quantitative assessment of the effectiveness of PRRSV vaccination in pigs under experimental conditions. Vaccine, 19(27): 3636-3644.
Tamura, K., et al., MEGA6: molecular evolutionary genetics analysis version 6.0. Molecular biology and evolution, 2013: p. mst197.
Thi Dieu Thuy, N., et al. (2013). Genetic analysis of ORF5 porcine reproductive and respiratory syndrome virus isolated in Vietnam. Microbiology and immunology, 57(7): 518-526.
Zuckermann, F.A., et al. (2007). Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters of protection upon challenge. Veterinary microbiology, 123(1): 69-85.
Kim, H., et al. (2011). The assessment of efficacy of porcine reproductive respiratory syndrome virus inactivated vaccine based on the viral quantity and inactivation methods. Virology Journal,. 8: 323-323.